中国普外基础与临床杂志

中国普外基础与临床杂志

甲状腺乳头状癌合并慢性淋巴细胞性甲状腺炎的临床病理特征分析

查看全文

目的 分析甲状腺乳头状癌(PTC)合并慢性淋巴细胞性甲状腺炎(CLT)患者的临床病理特征。 方法 回顾性收集笔者所在医院 2014 年 1 月至 2017 年 1 月期间经病理学检查确诊为 PTC 的 756 例患者的临床病理资料,根据术后常规病理学检查结果是否合并 CLT 分为单纯 PTC 组(562 例)和 PTC 合并 CLT 组(194 例),比较 2 组患者在临床资料、超声特征、甲状腺功能指标及病理特征方面的差异有无统计学意义。 结果 PTC 合并 CLT 组女性患者比例,血清促甲状腺激素(TSH)、甲状腺球蛋白抗体(TG-Ab)和甲状腺过氧化物酶抗体(TPO-Ab)水平升高者以及多灶癌的比例均明显高于单纯 PTC 组(P<0.05),2 组患者在术前超声、癌灶大小、被膜侵犯、中央组淋巴结转移及 TNM 分期方面比较差异均无统计学意义(P>0.05);进一步多因素分析结果显示,女性、TG-Ab升高、TPO-Ab升高以及多灶癌是 PTC 合并 CLT 的独立风险预测因素(P<0.05)。 结论 PTC 与 CLT 之间可能存在一定的关联,合并 CLT 的 PTC 好发于女性,以多灶癌多见,但合并 CLT 并未增加 PTC 的侵袭性,这可能与 CLT 限制了 PTC 结节的发展有关,推测 CLT 可能是 PTC 的保护性因素。

Objective To analyze clinical and pathological features of patients with papillary thyroid carcinoma (PTC) with coexistent chronic lymphocytic thyroiditis (CLT). Methods The clinicopathologic data of 756 cases of PTC were collected from January 2014 to January 2017 in the First Affiliated Hospital, Xinjiang Medical University were collected. The patients were designed to observational group (PTC with coexistent CLT, n=194) and control group (simple PTC, n=562) according to whether CLT was diagnosed by pathology, then the clinical data, ultrasonic features, thyroid function, and pathological features in these two groups were compared. Results The proportion of the female patients, the proportions of theserum thyroid stimulating hormone and thyroid autoimmune antibodies (thyroglobulin antibody and thyroid peroxidase antibody), and the proportion of multifocal carcinoma in the observational group were significantly higher than those in the control group (P<0.05). There were no significant differences in the preoperative ultrasound, tumor diameter, thyroid capsule invasion, central lymph node metastasis, and TNM stage in these two groups (P>0.05). The results of the multivariate analysis showed that the female, serum thyroid autoimmune antibodies, and the multifocal carcinoma were the independent predictive factors of PTC with CLT (P<0.05). Conclusions There might be a certain correlation between PTC and CLT, PTC with coexistent CLT is more common in female patient and with multifocal carcinoma. With coexistent CLT does not increase invasion of PTC. This may be associated with limit of CLT to development of PTC nodules. It is speculated that CLT may be a protective factor of PTC.

关键词: 甲状腺肿瘤; 慢性淋巴细胞性甲状腺炎; 临床病理学特征

Key words: thyroid neoplasm; chronic lymphocytic thyroiditis; clinicopathologic feature

引用本文: 朱敏, 王护国, 张英, 吾甫尔·依马尔, 苗玉堂, 赛力克·马高维亚. 甲状腺乳头状癌合并慢性淋巴细胞性甲状腺炎的临床病理特征分析. 中国普外基础与临床杂志, 2018, 25(3): 307-311. doi: 10.7507/1007-9424.201708060 复制

登录后 ,请手动点击刷新查看全文内容。 没有账号,
登录后 ,请手动点击刷新查看图表内容。 没有账号,
1. Zhu Y, Zheng K, Zhang H, et al. The clinicopathologic differences of central lymph node metastasis in predicting lateral lymph node metastasis and prognosis in papillary thyroid cancer associated with or without Hashimoto's thyroiditis. Tumour Biol, 2016, 37(6): 8037-8045.
2. Zhang Y, Dai J, Wu T, et al. The study of the coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma. J Cancer Res Clin Oncol, 2014, 140(6): 1021-1026.
3. 刘捷. 甲状腺乳头状癌合并桥本氏甲状腺炎的临床病理特征. 现代肿瘤医学, 2016, 24(2): 222-225.
4. 陈诚, 余宁康, 龚进发, 等. 桥本甲状腺炎合并甲状腺乳头状癌的临床特点及外科治疗. 中华普通外科杂志, 2013, 28(7): 511-514.
5. Ahn D, Heo SJ, Park JH, et al. Clinical relationship between Hashimoto's thyroiditis and papillary thyroid cancer. Acta Oncol, 2011, 50(8): 1228-1234.
6. Eisenberg BL, Hensley SD. Thyroid cancer with coexistent Hashimoto's thyroiditis. Clinical assessment and management. Arch Surg, 1989, 124(9):1045-1047.
7. Kim SG, Seo HS, Lee HH, et al. Comparison of the differences in survival rates between the 7th and 8th editions of the AJCC TNM staging system for gastric adenocarcinoma: a single-institution study of 5 507 patients in Korea. J Gastric Cancer, 2017, 17(3): 212-219.
8. Tamimi DM. The association between chronic lymphocytic thyroiditis and thyroid tumors. Int J Surg Pathol, 2002, 10(2): 141-146.
9. Kebebew E, Treseler PA, Ituarte PH, et al. Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited. World J Surg, 2001, 25(5): 632-637.
10. 朱敏, 赛力克•马高维亚. 慢性淋巴细胞性甲状腺炎与甲状腺乳头状癌的相关性研究进展. 中国普外基础与临床杂志, 2017, 24(10): 1289-1294.
11. Girardi FM, Barra MB, Zettler CG. Papillary thyroid carcinoma: does the association with Hashimoto's thyroiditis affect the clinicopathological characteristics of the disease? Braz J Otorhinolaryngol, 2015, 81(3): 283-287.
12. 郝战宇, 李波. 桥本甲状腺炎合并甲状腺乳头状癌的临床及病理学特征. 山东大学学报(医学版), 2016, 54(6): 73-77.
13. 黄伟钦, 薛恩生, 林礼务, 等. 桥本甲状腺炎背景下甲状腺癌的超声表现探讨. 中华医学超声杂志(电子版), 2009, 6(3): 61-64.
14. 刘友忠, 于洋, 赵翠, 等. 甲状腺乳头状癌合并桥本甲状腺炎的临床生物学特性分析. 中华普通外科杂志, 2013, 28(4): 256-258.
15. 邓江波. 甲状腺乳头状癌合并桥本氏甲状腺炎的临床和病理特点. 深圳中西医结合杂志, 2016, 26(13): 90-92.
16. 刘明明, 高莹, 张杨, 等. 抗甲状腺球蛋白抗体的亲合力在 Graves 病与 Graves 病合并桥本甲状腺炎鉴别诊断中的意义. 大连: 中华医学会内分泌学分会, 中华医学会第九次全国内分泌学学术会议, 2010.
17. 张德杰, 林国樑, 张铭, 等. 桥本氏甲状腺炎合并甲状腺癌的临床及病理研究. 兰州大学学报(医学版), 2017, 43(1): 31-35.
18. 杜婧, 武心萍, 丁文波, 等. 桥本氏甲状腺炎合并甲状腺乳头状癌患者血清 Tg-Ab 和 TPO-Ab 浓度的变化. 江苏医药, 2017, 43(5): 379-380.
19. Azizi G, Keller JM, Lewis M, et al. Association of Hashimoto's thyroiditis with thyroid cancer. Endocr Relat Cancer, 2014, 21(6): 845-852.
20. 林琳, 郑向前, 刘磊, 等. 多灶性甲状腺乳头状癌的生物学特性及治疗分析. 中华普通外科杂志, 2010, 25(8): 621-623.
21. 周晓倩, 金慧, 郑淼, 等. 合并桥本甲状腺炎的甲状腺乳头状癌术式探讨. 中华普通外科杂志, 2016, 31(3): 236-237.
22. 茅建娅, 王薇, 别克扎提, 等. 甲状腺乳头状癌合并桥本甲状腺炎的临床病理研究. 中国普通外科杂志, 2016, 25(5): 665-669.
23. Konturek A, Barczyński M, Wierzchowski W, et al. Coexistence of papillary thyroid cancer with Hashimoto thyroiditis. Langenbecks Arch Surg, 2013, 398(3): 389-394.
24. 徐冬冬, 论语, 刘勋, 等. Graves 病合并 PTC 与桥本甲状腺炎合并 PTC 的临床及病理特征比较. 中华医学杂志, 2017, 97(32): 2491-2495.
25. 伦语, 吴小雨, 辛世杰, 等. 桥本甲状腺炎与甲状腺乳头状癌关系的临床研究. 中国普通外科杂志, 2014, 23(5):484-590.